08.01.2025 14:24:34

Synopsys Issues Statement In Response To CMA's Provisional Acceptance Of Proposed Remedies

(RTTNews) - Synopsys (SNPS) said the company is very pleased that the CMA has taken the important step of provisionally accepting proposed remedies in Phase 1 regarding proposed acquisition of Ansys (ANSS), rather than referring the transaction to Phase 2. The company continues to expect the transaction to close in the first half of 2025.

"We will maintain our constructive and collaborative engagement with the CMA as it completes its process. Customers continue to express their overwhelming support for the transaction," Synopsys stated.

Analysen zu Synopsys Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ANSYS Inc. 327,30 -3,85% ANSYS Inc.
Synopsys Inc. 481,25 -7,61% Synopsys Inc.